The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

Two new gene therapies—from Novartis and Spark—carry price tags higher than any other drugs in the U.S., elbowing aside the brands we've seen at the top for years, a GoodRx analysis shows. And with drugmakers doubling down in rare diseases, the trend will likely continue.